07:00 Wed 02 Dec 2020
NetScientific PLC - Board changes and Grant of Options
NetScientific plc
("NetScientific", the "Group" or the "Company")
Board changes and grant of Options
1. Appointment of
2. Appointment of
3. Additional responsibilities for Professor
4. Confirmation of
5. Grant of options to Directors and senior management.
Dr.
1. Appointment of
John joined the NetScientific Board in
2. Appointment of
The NetScientific Board is pleased to announce that
Clive is an experienced Director and Chairman of an Audit committee, with a background at the NHS, PWC and HM Treasury. He is also a Non-Executive Director serving on the board of the largest community healthcare NHS Trust in
Clive had a successful career as a management consultant with two professional services firms: Grant Thornton and PricewaterhouseCoopers (PwC). For three years, he worked as a Director in HM Treasury, driving the delivery of a successful change programme. He has also set up and led two profitable start-up companies.
Clive is a Fellow of the Association of Chartered Certified Accountants, a Chartered Public Finance Accountant and a member of the Healthcare Financial Management Association. He holds a degree in Economics from the University of Nottingham.
| Current directorships |
| Past Directorships & Partnerships |
| Central London Community Healthcare NHS Trust |
| Pareto Management Ltd |
|
|
| The Childhood Trust |
No further disclosure is required under Paragraph (g) to Schedule Two of the AIM Rules for Companies.
3. Appointment of Prof.
Professor
4. Appointment of
We are pleased to confirm the appointment of
5. Grant of Options to Directors/Senior Management
In line with the priorities identified in the circular, the NetScientific Remuneration Committee has approved the award of the following options:
| Director | Number of existing options held | Number of New Options granted | Total number of options held |
| | 0 | 382,465 | 382,465 |
| | 3,000 | 46,155 | 49,155 |
| | 0 | 46,155 | 46,155 |
| | 0 | 46,155 | 46,155 |
The grant of the New Options represents the recommendations of the Board's Remuneration Committee, in respect of remuneration arrangements for Directors and senior management.
The New Options were granted under the NetScientific Share Option Scheme, pursuant to which options over a total of 1,263,993 Ordinary Shares have now been granted, representing 8.47 per cent. of the current issued share capital of the Company. The maximum potential dilution arising from options awarded under the NetScientific Share Option Scheme remains below the upper limit of 10 per cent. under the rules of the plan.
The New Options have an exercise price of
The New Options will vest as to one third on the date of grant, as to a further third on the first anniversary of the date of grant and as to the final third on the second anniversary of the date of grant. The New Options may not be exercised earlier than the third anniversary of the date of grant. The New Options lapse 10 years after the date of grant (if not sooner in accordance with the terms of the NetScientific Share Option Scheme rules).
The FCA notifications, made in accordance with the requirements of the EU Market Abuse Regulation, are appended below.
About ProAxsis
ProAxsis Limited is a commercial-stage diagnostics company, based in
In addition to proteases, the company also has significant expertise in the measurement of other inflammatory biomarkers, including IL-6, IL-8 and TNF-alpha.
Aside from the provision of assays, ProAxsis is able to offer a sample analysis service at its purpose-built laboratory facility in
ProAxsis is a fully owned subsidiary of NetScientific Plc.
To learn more about ProAxsis, please visit www.proaxsis.com.
About Glycotest Inc.
Glycotest Inc. is a private liver disease diagnostics company commercializing novel clinical laboratory testing services for patients with serious liver disease, and a subsidiary of NetScientific. The Company was founded in 2012 on proprietary technology that originated at the
Glycotest is a 65.6% subsidiary of NetScientific Plc.
To learn more about Glycotest, please visit: www.Glycotest.com.
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Following the publication of this announcement, this inside information is now considered to be in the public domain.
For more information, please contact:
NetScientific
WH Ireland (NOMAD, Financial Adviser and Broker)
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the grant of options to PDMRs.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chairman, NetScientific plc | ||||
| b) | Initial notification/ Amendment | Initial Notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | NetScientific plc | ||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Options over Ordinary Shares
ISIN for NetScientific plc Ordinary Shares: GB00BN4R5Q82 | ||||
| b) | Nature of the transaction | Grant of options | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price - Aggregated total | N/A | ||||
| e) | Date of the transaction | | ||||
| f) | Place of the transaction | Outside a trading venue | ||||
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Prof. | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Non-executive Director, NetScientific plc | ||||
| b) | Initial notification/ Amendment | Initial Notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | NetScientific plc | ||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Options over Ordinary Shares
ISIN for NetScientific plc Ordinary Shares: GB00BN4R5Q82 | ||||
| b) | Nature of the transaction | Grant of options | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price - Aggregated total | N/A | ||||
| e) | Date of the transaction | | ||||
| f) | Place of the transaction | Outside a trading venue | ||||
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Non-executive Director, NetScientific plc | ||||
| b) | Initial notification/ Amendment | Initial Notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | NetScientific plc | ||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Options over Ordinary Shares
ISIN for NetScientific plc Ordinary Shares: GB00BN4R5Q82 | ||||
| b) | Nature of the transaction | Grant of options | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price - Aggregated total | N/A | ||||
| e) | Date of the transaction | | ||||
| f) | Place of the transaction | Outside a trading venue | ||||
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | CFO, NetScientific plc | ||||
| b) | Initial notification/ Amendment | Initial Notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | NetScientific plc | ||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Options over Ordinary Shares
ISIN for NetScientific plc Ordinary Shares: GB00BN4R5Q82 | ||||
| b) | Nature of the transaction | Grant of options | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price - Aggregated total | N/A | ||||
| e) | Date of the transaction | | ||||
| f) | Place of the transaction | Outside a trading venue | ||||
About NetScientific
NetScientific is a life sciences, technology, investment and commercialisation Group, leveraging trans-Atlantic relationships and global opportunities to deliver shareholder value.
For more information, please visit the website at www.NetScientific.net
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive
